EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Pilot Study to Test the Feasibility of a Randomized Controlled Trial of E-cigarettes as Harm Reduction Tools Among People Who Smoke and Previously Failed to Quit With Pharmacotherapy

Tracy T Smith iD, Anna Ferreira, Amy E Wahlquist, K Michael Cummings iD, Alana M Rojewski iD, Erin A McClure iD, Benjamin A Toll iD, Matthew J Carpenter iD

Nicotine and Tobacco Research · 2025

DOI: 10.1093/ntr/ntae212 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Tracy T Smith und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Smoking Cessation, Harm Reduction, Tobacco Use Cessation Devices. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: Institutional Research Grant from the American Cancer Society, Hollings Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We conducted a pilot study to test the feasibility of a future randomized controlled trial comparing e-cigarettes to traditional pharmacotherapy among people who smoke daily, were motivated to quit, and failed to quit within the past 5 years using pharmacotherapy. Aims and Methods Eligible participants were assigned to either: (1) an e-cigarette (n = 20) or (2) combination nicotine replacement therapy (NRT; patches and lozenges; n = 10). Participants received 5 weeks of product and selected a quit date 1 week later. Assessments were completed weekly, and electronic diaries were completed each day. As a pilot randomized controlled trial, outcomes focus on effect sizes and not statistical significance.

Results

Participants in the e-cigarette and NRT groups had a mean age of 51 (SD = 13) and 50 (SD = 10) years old, were 55% and 60% female, and were 15% and 0% nonWhite, respectively. At least 90% of participants completed each weekly assessment and 77% of participants completed at least 80% of daily diaries. Mean cigarettes smoked per day reduced from 18 (SD = 6.2) to 2.4 (SD = 4.4) per day in the e-cigarette group and 16.5 (SD = 8.5) to 4.9 (SD = 5.9) per day in the NRT group. Rates of biochemically confirmed 7-day point-prevalence abstinence at the end of treatment were numerically, but not statistically, higher in the e-cigarette group than the NRT group (35% vs. 10%, OR = 4.8, 95% CI = 0.5 to 46.5).

Conclusions

Among current daily cigarette smokers who have previously tried to quit and failed with standard pharmacotherapies, the provision of an e-cigarette is a feasible intervention. A larger adequately powered trial is warranted.

Implications

This pilot study suggests that e-cigarettes may serve as an acceptable harm reduction intervention for people who smoke but cannot quit smoking with traditional pharmacotherapy, however, adequately powered randomized controlled trials are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Nicotine Delivery SystemsSmoking CessationHarm ReductionTobacco Use Cessation DevicesHumansPilot ProjectsFemaleMaleMiddle AgedFeasibility StudiesAdult

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • MUSC Hollings Cancer Center, Charleston, SC, USA.
  • Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Center for Rural Health Research, East Tennessee State University, Johnson City, TN, USA.

ORCID-Profile: Tracy T Smith, K Michael Cummings, Alana M Rojewski, Erin A McClure, Benjamin A Toll, Matthew J Carpenter

Förderung

  • Institutional Research Grant from the American Cancer Society
  • Hollings Cancer Center

Zitieren

APA

Smith, T. T., Ferreira, A., Wahlquist, A. E., Cummings, K. M., Rojewski, A. M., McClure, E. A., Toll, B. A., & Carpenter, M. J. (2025). A Pilot Study to Test the Feasibility of a Randomized Controlled Trial of E-cigarettes as Harm Reduction Tools Among People Who Smoke and Previously Failed to Quit With Pharmacotherapy. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae212

Vancouver

Smith TT, Ferreira A, Wahlquist AE, Cummings KM, Rojewski AM, McClure EA, et al. A Pilot Study to Test the Feasibility of a Randomized Controlled Trial of E-cigarettes as Harm Reduction Tools Among People Who Smoke and Previously Failed to Quit With Pharmacotherapy. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntae212

BibTeX
@article{Smith2025,
  author = {Smith, Tracy T and Ferreira, Anna and Wahlquist, Amy E and Cummings, K Michael and Rojewski, Alana M and McClure, Erin A and Toll, Benjamin A and Carpenter, Matthew J},
  title = {A Pilot Study to Test the Feasibility of a Randomized Controlled Trial of E-cigarettes as Harm Reduction Tools Among People Who Smoke and Previously Failed to Quit With Pharmacotherapy},
  journal = {Nicotine and Tobacco Research},
  year = {2025},
  doi = {10.1093/ntr/ntae212}
}
Kostenlos starten →